Seres Therapeutics Inc (MCRB) — Capital Reinvestment Ratio
Seres Therapeutics Inc (MCRB) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($2.21 Million) in capital expenditures ($8.00K). Check Seres Therapeutics Inc (MCRB) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Seres Therapeutics Inc Capital Reinvestment Ratio (2016–2025)
This chart tracks Seres Therapeutics Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Seres Therapeutics Inc (MCRB) cash flow conversion.
Annual Capital Reinvestment Ratio for Seres Therapeutics Inc (2016–2025)
Year-by-year Capital Reinvestment Ratio for Seres Therapeutics Inc from 2016 to 2025. See Seres Therapeutics Inc (MCRB) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | $1.12 Million | $252.00K | ▼ -84.2% |
| 2021 | 1.43x | $6.69 Million | $9.57 Million | ▲ +192.3% |
| 2016 | 0.49x | $43.92 Million | $21.49 Million | — |